Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H34O2 |
Molecular Weight | 318.4935 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@]4([H])C[C@@H](O)CC[C@]34C
InChI
InChIKey=AURFZBICLPNKBZ-GRWISUQFSA-N
InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16+,17-,18+,19+,20+,21-/m1/s1
Molecular Formula | C21H34O2 |
Molecular Weight | 318.4935 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1320747Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/11978813 | https://www.ncbi.nlm.nih.gov/pubmed/15950269 | https://www.ncbi.nlm.nih.gov/pubmed/24800894 |
https://www.ncbi.nlm.nih.gov/pubmed/20735426 | https://www.ncbi.nlm.nih.gov/pubmed/9396781
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1320747
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/11978813 | https://www.ncbi.nlm.nih.gov/pubmed/15950269 | https://www.ncbi.nlm.nih.gov/pubmed/24800894 |
https://www.ncbi.nlm.nih.gov/pubmed/20735426 | https://www.ncbi.nlm.nih.gov/pubmed/9396781
Epipregnanolone is an epimer of endogenous neurosteroid pregnanolone, it has been shown to antagonize GABAA and NMDA receptors. In addition epipregnanolone inhibits calcium T-currents and stimulates TRPM3 channel. Epipregnanolone displays anesthetic properties. Epipregnanolone has been shown to reduce alcohol self-administration in rats.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1859 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24800894 |
|||
10.5 µM [Ki] | |||
Target ID: Q9HCF6|||Q86SH6|||Q86Z01 Gene ID: 80036.0 Gene Symbol: TRPM3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/20735426 |
|||
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9396781 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24800894 |
Primary | Unknown Approved UseUnknown |
||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Characterization of discriminative stimulus effects of the neuroactive steroid pregnanolone. | 2001 May |
|
Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys. | 2003 Jan |
|
Altered profiles of serum neuroactive steroids in premenopausal women treated for alcohol addiction. | 2005 Jul |
|
Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy. | 2007 Oct |
|
Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential. | 2008 Dec 3 |
Sample Use Guides
Intraperitoneal epipregnanolone (5, 10, and 20 mg/kg) dose-dependently attenuated ethanol self-administration in rats.
Intraplantar injections (0.1, 1 or 10 uM) of epipregnanolone directly into peripheral receptive fields reduced responses to nociceptive stimuli in rodents in a dose-dependent fashion.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24800894
Epipregnanolone reversibly blocked T-type calcium channels in rat dorsal root ganglia (DRG) cells in vitro in a dose-dependent fashion (IC50 = 2 μM) and stabilized the channel in the inactive state.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:06:22 GMT 2023
by
admin
on
Fri Dec 15 15:06:22 GMT 2023
|
Record UNII |
3KQ00893OL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
78376-1
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
||
|
LOINC |
81775-9
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
||
|
LOINC |
78379-5
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
||
|
LOINC |
78377-9
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID00155766
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
PRIMARY | |||
|
Epipregnanolone
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
PRIMARY | |||
|
3KQ00893OL
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
PRIMARY | |||
|
16229
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
PRIMARY | |||
|
21450
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
PRIMARY | |||
|
128-21-2
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
PRIMARY | |||
|
228491
Created by
admin on Fri Dec 15 15:06:22 GMT 2023 , Edited by admin on Fri Dec 15 15:06:22 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |